309 related articles for article (PubMed ID: 25940848)
21. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
23. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F
Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830
[TBL] [Abstract][Full Text] [Related]
25. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
26. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
27. Cyclodextrin based unimolecular micelles with targeting and biocleavable abilities as chemotherapeutic carrier to overcome drug resistance.
Li W; Xu C; Li S; Chen X; Fan X; Hu Z; Wu YL; Li Z
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110047. PubMed ID: 31546452
[TBL] [Abstract][Full Text] [Related]
28. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
29. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
30. Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs.
Feng S; Zhang H; Yan T; Huang D; Zhi C; Nakanishi H; Gao XD
Int J Nanomedicine; 2016; 11():4573-4582. PubMed ID: 27695318
[TBL] [Abstract][Full Text] [Related]
31. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
32. Selectivity of folate conjugated polymer micelles against different tumor cells.
Zhao H; Yung LY
Int J Pharm; 2008 Feb; 349(1-2):256-68. PubMed ID: 17850996
[TBL] [Abstract][Full Text] [Related]
33. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
Xu W; Lou Y; Chen W; Kang Y
Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
[TBL] [Abstract][Full Text] [Related]
34. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
Yoo HS; Park TG
J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.
Ye WL; Teng ZH; Liu DZ; Cui H; Liu M; Cheng Y; Yang TH; Mei QB; Zhou SY
J Pharm Sci; 2013 Feb; 102(2):530-40. PubMed ID: 23169439
[TBL] [Abstract][Full Text] [Related]
36. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
37. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
[TBL] [Abstract][Full Text] [Related]
38. Folate appended cyclodextrins for drug, DNA, and siRNA delivery.
Ceborska M
Eur J Pharm Biopharm; 2017 Nov; 120():133-145. PubMed ID: 28893691
[TBL] [Abstract][Full Text] [Related]
39. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
40. Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.
Zhang L; Lu J; Jin Y; Qiu L
Colloids Surf B Biointerfaces; 2014 Oct; 122():260-269. PubMed ID: 25058857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
